0
0
10/17/22 at 4:23pm
Organization
Pulmonologyadvisor.com
Author
melissaalvarez
35 words
0
Comments
A post hoc analysis of the NAVIGATOR trial assessed the effectiveness of tezepelumab in patients with severe asthma who used additional controllers medications.
You are the first to view
https://www.pulmonologyadvisor.com/home/meetings/chest-2022/tezepelumab-improves-severe-asthma-even-in-those-using-multiple-controllers/
Create an account
or login to join the discussion